AI-Powered Drug Discovery Platform Transforms Broad Antiviral Development with Rick Pierce Decoy Therapeutics TRANSCRIPT
Download PDFDec 17, 2025
Rick Pierce, Co-Founder and CEO of Decoy Therapeutics. is using AI and machine learning to accelerate drug discovery and is developing broad-acting antivirals using peptide conjugates that target a shared invasion mechanism of hundreds of viruses. The company is using small language models and a high-speed...
Dec 17, 2025
Rick Pierce, Co-Founder and CEO of Decoy Therapeutics. is using AI and machine learning to accelerate drug discovery and is developing broad-acting antivirals using peptide conjugates that target a shared invasion mechanism of hundreds of viruses. The company is using small language models and a high-speed...
Peptide Therapy for Low T Restores Natural Testosterone Production with Dr. Costas Karatzas Acesis BioMed TRANSCRIPT
Download PDFOct 29, 2025
Dr. Costas Karatzas, CEO, Director, and Co-Founder of Acesis BioMed, is focused on developing a novel treatment for low testosterone in men, an oral peptide that stimulates the body to restore its own natural testosterone production. The therapy's mechanism differs from current testosterone replacement therapies and...
Oct 29, 2025
Dr. Costas Karatzas, CEO, Director, and Co-Founder of Acesis BioMed, is focused on developing a novel treatment for low testosterone in men, an oral peptide that stimulates the body to restore its own natural testosterone production. The therapy's mechanism differs from current testosterone replacement therapies and...
Targeting Inflammation and Cancer with Innovative Peptide Therapies with Haitham Ayad SPIMA Therapeutics TRANSCRIPT
Download PDFDec 10, 2024
Haitham Ayad, CEO of SPIMA Therapeutics, has secured a global licensing agreement for its lead peptide-based immunotherapy candidate, which targets the Myddosome complex involved in inflammation. This approach aims to target undruggable protein-protein interactions, leveraging the advantages of peptides over small...